Follow-up evaluation of a web-based pediatric brain tumor board in Latin America

Standard

Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. / Rosabal-Obando, Mariel; Osorio, Diana S; Lassaletta, Alvaro; La Madrid, Andrés Morales; Bartels, Ute; Finlay, Jonathan L; Qaddoumi, Ibrahim; Rutkowski, Stefan; Mynarek, Martin.

In: PEDIATR BLOOD CANCER, Vol. 68, No. 9, 09.2021, p. e29073.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rosabal-Obando, M, Osorio, DS, Lassaletta, A, La Madrid, AM, Bartels, U, Finlay, JL, Qaddoumi, I, Rutkowski, S & Mynarek, M 2021, 'Follow-up evaluation of a web-based pediatric brain tumor board in Latin America', PEDIATR BLOOD CANCER, vol. 68, no. 9, pp. e29073. https://doi.org/10.1002/pbc.29073

APA

Rosabal-Obando, M., Osorio, D. S., Lassaletta, A., La Madrid, A. M., Bartels, U., Finlay, J. L., Qaddoumi, I., Rutkowski, S., & Mynarek, M. (2021). Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. PEDIATR BLOOD CANCER, 68(9), e29073. https://doi.org/10.1002/pbc.29073

Vancouver

Rosabal-Obando M, Osorio DS, Lassaletta A, La Madrid AM, Bartels U, Finlay JL et al. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. PEDIATR BLOOD CANCER. 2021 Sep;68(9):e29073. https://doi.org/10.1002/pbc.29073

Bibtex

@article{112cb6b595e047d68a98124f7628482d,
title = "Follow-up evaluation of a web-based pediatric brain tumor board in Latin America",
abstract = "BACKGROUND: Since 2013, pediatric oncologists from Central and South America discuss neuro-oncology cases with experts from North America and Europe in a web-based {"}Latin American Tumor Board{"} (LATB). Here, we evaluate the feasibility of recommendations rendered by the Board.METHODS: An electronic questionnaire was distributed to physicians who had received recommendations between October 2017 and October 2018. Physicians were asked regarding the feasibility of each recommendation given during the LATB discussion. Baseline case characteristics of all presented cases were obtained from anonymized minutes.RESULTS: Of the 142 patients discussed, data on 103 patients from 15 countries were available, corresponding to 283 recommendations. Physicians followed 60% of diagnostic procedural recommendations and 69% of therapeutic recommendations. The most difficult recommendations to follow were genetic and molecular testing, pathology review, chemotherapy, surgery, and molecular targeted therapies. Histological diagnoses changed in eight of 18 cases in which a pathology review was undertaken. Fifty-four percent of the recommendations that could not be implemented were considered not feasible in the specific context of the patient, while 31% were not implemented due to a decision of the medical staff or the parents (15% not specified). However, 96% of respondents considered the recommendations useful.CONCLUSION: Recommendations were frequently perceived as useful, and were applicable in the participating institutions. Nevertheless, limitations in availability of diagnostic procedures and treatment modalities affected the feasibility of some recommendations. Tele-oncology tumor boards offer physicians from low- and middle-income countries access to real-time, high-level subspecialist expertise and provide a valuable platform for worldwide information exchange.",
author = "Mariel Rosabal-Obando and Osorio, {Diana S} and Alvaro Lassaletta and {La Madrid}, {Andr{\'e}s Morales} and Ute Bartels and Finlay, {Jonathan L} and Ibrahim Qaddoumi and Stefan Rutkowski and Martin Mynarek",
note = "{\textcopyright} 2021 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.",
year = "2021",
month = sep,
doi = "10.1002/pbc.29073",
language = "English",
volume = "68",
pages = "e29073",
journal = "PEDIATR BLOOD CANCER",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Follow-up evaluation of a web-based pediatric brain tumor board in Latin America

AU - Rosabal-Obando, Mariel

AU - Osorio, Diana S

AU - Lassaletta, Alvaro

AU - La Madrid, Andrés Morales

AU - Bartels, Ute

AU - Finlay, Jonathan L

AU - Qaddoumi, Ibrahim

AU - Rutkowski, Stefan

AU - Mynarek, Martin

N1 - © 2021 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.

PY - 2021/9

Y1 - 2021/9

N2 - BACKGROUND: Since 2013, pediatric oncologists from Central and South America discuss neuro-oncology cases with experts from North America and Europe in a web-based "Latin American Tumor Board" (LATB). Here, we evaluate the feasibility of recommendations rendered by the Board.METHODS: An electronic questionnaire was distributed to physicians who had received recommendations between October 2017 and October 2018. Physicians were asked regarding the feasibility of each recommendation given during the LATB discussion. Baseline case characteristics of all presented cases were obtained from anonymized minutes.RESULTS: Of the 142 patients discussed, data on 103 patients from 15 countries were available, corresponding to 283 recommendations. Physicians followed 60% of diagnostic procedural recommendations and 69% of therapeutic recommendations. The most difficult recommendations to follow were genetic and molecular testing, pathology review, chemotherapy, surgery, and molecular targeted therapies. Histological diagnoses changed in eight of 18 cases in which a pathology review was undertaken. Fifty-four percent of the recommendations that could not be implemented were considered not feasible in the specific context of the patient, while 31% were not implemented due to a decision of the medical staff or the parents (15% not specified). However, 96% of respondents considered the recommendations useful.CONCLUSION: Recommendations were frequently perceived as useful, and were applicable in the participating institutions. Nevertheless, limitations in availability of diagnostic procedures and treatment modalities affected the feasibility of some recommendations. Tele-oncology tumor boards offer physicians from low- and middle-income countries access to real-time, high-level subspecialist expertise and provide a valuable platform for worldwide information exchange.

AB - BACKGROUND: Since 2013, pediatric oncologists from Central and South America discuss neuro-oncology cases with experts from North America and Europe in a web-based "Latin American Tumor Board" (LATB). Here, we evaluate the feasibility of recommendations rendered by the Board.METHODS: An electronic questionnaire was distributed to physicians who had received recommendations between October 2017 and October 2018. Physicians were asked regarding the feasibility of each recommendation given during the LATB discussion. Baseline case characteristics of all presented cases were obtained from anonymized minutes.RESULTS: Of the 142 patients discussed, data on 103 patients from 15 countries were available, corresponding to 283 recommendations. Physicians followed 60% of diagnostic procedural recommendations and 69% of therapeutic recommendations. The most difficult recommendations to follow were genetic and molecular testing, pathology review, chemotherapy, surgery, and molecular targeted therapies. Histological diagnoses changed in eight of 18 cases in which a pathology review was undertaken. Fifty-four percent of the recommendations that could not be implemented were considered not feasible in the specific context of the patient, while 31% were not implemented due to a decision of the medical staff or the parents (15% not specified). However, 96% of respondents considered the recommendations useful.CONCLUSION: Recommendations were frequently perceived as useful, and were applicable in the participating institutions. Nevertheless, limitations in availability of diagnostic procedures and treatment modalities affected the feasibility of some recommendations. Tele-oncology tumor boards offer physicians from low- and middle-income countries access to real-time, high-level subspecialist expertise and provide a valuable platform for worldwide information exchange.

U2 - 10.1002/pbc.29073

DO - 10.1002/pbc.29073

M3 - SCORING: Journal article

C2 - 34003601

VL - 68

SP - e29073

JO - PEDIATR BLOOD CANCER

JF - PEDIATR BLOOD CANCER

SN - 1545-5009

IS - 9

ER -